Bio Green Med Solution, Inc. Files 8-K on Officer/Director Changes
Ticker: BGMSP · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1130166
Sentiment: neutral
Topics: officer-changes, director-changes, corporate-governance, financial-statements
Related Tickers: BGMS
TL;DR
BGMS filed an 8-K for officer/director changes and financial statements as of 9/19/25.
AI Summary
Bio Green Med Solution, Inc. filed an 8-K on September 25, 2025, reporting events as of September 19, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- Bio Green Med Solution, Inc. (company) — Registrant
- September 19, 2025 (date) — Date of earliest event reported
- September 25, 2025 (date) — Date of report
- Cyclacel Pharmaceuticals, Inc. (company) — Former company name
- XCYTE THERAPIES INC (company) — Former company name
FAQ
What specific officer or director positions were affected by the events reported in this 8-K?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the names or exact positions in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was as of September 19, 2025.
What is the SIC code for Bio Green Med Solution, Inc.?
The Standard Industrial Classification (SIC) code for Bio Green Med Solution, Inc. is 2834, Pharmaceutical Preparations.
What were the former names of Bio Green Med Solution, Inc.?
The company was formerly known as Cyclacel Pharmaceuticals, Inc. and XCYTE THERAPIES INC.
What items are covered in this 8-K filing?
This 8-K covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; and Financial Statements and Exhibits.
Filing Stats: 956 words · 4 min read · ~3 pages · Grade level 11 · Accepted 2025-09-24 18:14:14
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BGMS The Nasdaq Capital M
- $1,000.00 — compensate Ms. Pappas in the amount of $1,000.00 per month for her service on the Board.
Filing Documents
- form8-k.htm (8-K) — 49KB
- form8-k_001.jpg (GRAPHIC) — 6KB
- 0001493152-25-014840.txt ( ) — 276KB
- bgms-20250919.xsd (EX-101.SCH) — 4KB
- bgms-20250919_def.xml (EX-101.DEF) — 26KB
- bgms-20250919_lab.xml (EX-101.LAB) — 36KB
- bgms-20250919_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 25, 2025 Bio Green Med Solution, Inc. By: /s/ Datuk Dr. Doris Wong Sing Ee Name: Datuk Dr. Doris Wong Sing Ee Title: Chief Executive Officer and Executive Director